Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
about
Biostatistics: a toolkit for exploration, validation, and interpretation of clinical data.Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage IIITumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.Specific organ metastases and survival in small cell lung cancerBenefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer.The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study.Progress in the management of limited-stage small cell lung cancer.Importance of ABCC1 for cancer therapy and prognosis.Prognostic value of Ki-67 expression in patients with extensive-stage small cell lung cancer.Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma.Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions.A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.[First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries
P2860
Q33518386-0785AED2-6C8E-423C-A361-26043985D750Q33798652-D1446304-F95E-44F1-93D0-0630F96E7FD4Q34512144-FE336E0A-E05E-487E-9D21-3836E4566F0AQ34991328-069082BF-E481-44E9-A2C3-27A4017ECD74Q36424117-1453CC0D-4340-42E5-A0B6-F1C6738BC4DAQ36657575-0F82DE73-7555-4DDB-9ABA-B2F69697977BQ36707857-9364249E-6502-40B4-8E76-77C68490789CQ36857674-EEACB6F8-F6F0-4F68-A5F8-54A7945399E9Q37178855-C3B76214-8A61-40F7-BFC4-E81472BCA483Q37283557-E1B3C36B-91A2-4B5D-B860-FAAAE21FBA32Q37626969-75162F95-C84E-4A47-B59F-4D6416B27AA0Q38199535-31741D1F-87CA-444E-B759-B96267D24670Q38673828-071B5CBC-145D-471C-B14E-62382D9144E7Q38996164-D20AE1C0-059D-460B-92BE-5DF45DB4AE8BQ40269165-44FE6F39-D34B-4A4F-9D3B-0376B84D24B6Q43139088-CFB32F20-FFEB-4CF8-8659-14ECBAFAA4B4Q45226424-C19EB258-FBD3-4C0D-AD37-B48041A8953BQ48277835-52B66DD0-3420-4AEF-AF79-1D95E01950F7Q49344235-7CFA08B3-EAFC-4417-A7BE-3151A1671B90Q51701867-5769DF8B-3274-4867-A017-B39F7557DFDAQ53109417-D420CB77-5210-428D-BAE6-084147C70BAAQ55428299-4F78146B-1F74-4C08-888E-29642ECCE736Q59127285-B449EEEB-B4CB-4A81-B20C-B596C20BE56E
P2860
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@ast
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@en
type
label
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@ast
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@en
prefLabel
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@ast
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@en
P2093
P2860
P356
P1433
P1476
Prognostic factors differ by t ...... Cancer Treatment Group trials.
@en
P2093
Alex A Adjei
Garth D Nelson
James R Jett
Kendrith M Rowland
Nathan R Foster
Randolph S Marks
Richard L Deming
Sumithra J Mandrekar
Timothy F Kozelsky
P2860
P304
P356
10.1002/CNCR.24314
P407
P577
2009-06-01T00:00:00Z